Literature DB >> 1766498

Blood and urinary aggregator and inhibitor composition in controls and renal-stone patients from northeastern Thailand.

P Sriboonlue1, V Prasongwattana, K Tungsanga, P Tosukhowong, P Phantumvanit, O Bejraputra, V Sitprija.   

Abstract

Renal-stone disease (RSD) is common in the rural communities of northeastern Thailand. We report the biochemical composition of blood and urine in 25 healthy city dwellers (G1), 12 healthy village dwellers (G2) and 25 village dwellers who had RSD (G3). They were male with a range of ages between 20 and 50 years and were free of renal failure, urinary infection, urinary obstruction and systemic illness. The results showed that hypocitraturia, hypokalemia and hypokaliuria were more common in the latter 2 groups. The 24-h urinary citrate excretion correlated significantly with urinary potassium in G3 cases (r = 0.704, p = 0.0002). After potassium chloride supplementation, serum and urinary potassium increased remarkably (p less than 0.003 and p = 0.002, respectively), whereas urinary citrate remained unchanged. Our results suggest that the predominant abnormality in our RSD patients were hypocitraturia and potassium deficiency and that these may be related.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1766498     DOI: 10.1159/000186649

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  8 in total

1.  Renal tubular cell damage and oxidative stress in renal stone patients and the effect of potassium citrate treatment.

Authors:  Kriang Tungsanga; Pote Sriboonlue; Prasit Futrakul; Chatchai Yachantha; Piyaratana Tosukhowong
Journal:  Urol Res       Date:  2004-11-25

2.  Evidence suggesting a genetic contribution to kidney stone in northeastern Thai population.

Authors:  Suchai Sritippayawan; Sombat Borvornpadungkitti; Atchara Paemanee; Chagkrapan Predanon; Wattanachai Susaengrat; Duangporn Chuawattana; Nunghathai Sawasdee; Sirintra Nakjang; Suttikarn Pongtepaditep; Choochai Nettuwakul; Nanyawan Rungroj; Somkiat Vasuvattakul; Prida Malasit; Pa-thai Yenchitsomanus
Journal:  Urol Res       Date:  2009-04-22

3.  Urinary lithogenic and inhibitory factors in preterm neonates receiving either total parenteral nutrition or milk formula.

Authors:  Vasilios I Giapros; Athanasios L Papaloukas; Anna S Challa; Panagiotis D Nikolopoulos; Constantine G Tsampoulas; Styliani K Andronikou
Journal:  Eur J Pediatr       Date:  2003-05-16       Impact factor: 3.183

4.  Kidney stone inhibitors in patients with renal stones and endemic renal tubular acidosis in northeast Thailand.

Authors:  Yasushi Nakagawa; Mauricio Carvalho; Prida Malasit; Sumalee Nimmannit; Suchai Sritippaywan; Somkiat Vasuvattakul; Somchai Chutipongtanate; Vipada Chaowagul; Sanga Nilwarangkur
Journal:  Urol Res       Date:  2004-02-03

5.  Association between human prothrombin variant (T165M) and kidney stone disease.

Authors:  Nanyawan Rungroj; Nirinya Sudtachat; Choochai Nettuwakul; Nunghathai Sawasdee; Oranud Praditsap; Prapaporn Jungtrakoon; Suchai Sritippayawan; Duangporn Chuawattana; Sombat Borvornpadungkitti; Chagkrapan Predanon; Wattanachai Susaengrat; Pa-Thai Yenchitsomanus
Journal:  PLoS One       Date:  2012-09-19       Impact factor: 3.240

6.  Evaluation of the chemical composition of nephrolithiasis using dual-energy CT in Southern Chinese gout patients.

Authors:  Zhao-Xia Li; Gen-Long Jiao; Shu-Min Zhou; Zhong Yuan Cheng; Shoaib Bashir; Yi Zhou
Journal:  BMC Nephrol       Date:  2019-07-19       Impact factor: 2.388

7.  Orthosiphon versus placebo in nephrolithiasis with multiple chronic complaints: a randomized control trial.

Authors:  Amorn Premgamone; Pote Sriboonlue; Srinoi Maskasem; Wattana Ditsataporncharoen; Bungornsri Jindawong
Journal:  Evid Based Complement Alternat Med       Date:  2007-10-25       Impact factor: 2.629

8.  Loss-of-function mutations of SCN10A encoding NaV1.8 α subunit of voltage-gated sodium channel in patients with human kidney stone disease.

Authors:  Choochai Nettuwakul; Oranud Praditsap; Nunghathai Sawasdee; Nanyawan Rungroj; Katesirin Ruamyod; Wattana B Watanapa; Mutita Junking; Sittideth Sangnual; Suchai Sritippayawan; Boonyarit Cheunsuchon; Duangporn Chuawattana; Santi Rojsatapong; Wipada Chaowagul; Sulayman D Dib-Hajj; Stephen G Waxman; Pa-Thai Yenchitsomanus
Journal:  Sci Rep       Date:  2018-07-11       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.